Kane Biotech Inc. | Balance Sheet
Fiscal year is January-December. All values CAD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
634.40
966.20
116.30
739.60
1,975.70
75.40
Total Accounts Receivable
216.80
56.20
134.80
71.90
118.40
116.30
Inventories
-
26.00
63.70
213.70
135.20
324.50
Other Current Assets
35.80
109.80
29.40
60.20
20.90
40.40
Total Current Assets
887.00
1,158.20
344.30
1,085.30
2,250.20
556.60
Net Property, Plant & Equipment
42.20
38.70
39.80
63.10
60.30
54
Intangible Assets
954.30
792.50
789.00
982.80
1,086.60
945.40
Total Assets
1,883.50
1,989.40
1,173.10
2,131.20
3,397.10
1,555.90
ST Debt & Current Portion LT Debt
-
448.50
-
480.00
-
Accounts Payable
87.90
92.60
110.80
135.90
224.20
Other Current Liabilities
99.20
123.40
143.40
167.80
434.80
Total Current Liabilities
187.10
664.50
254.20
783.70
659.00
Long-Term Debt
413.20
25.50
468.60
30.00
-
Total Liabilities
600.30
690.00
722.80
813.70
659.00
Common Equity (Total)
1,283.20
1,299.40
450.30
1,317.50
2,738.10
Total Shareholders' Equity
1,283.20
1,299.40
450.30
1,317.50
2,738.10
Total Equity
1,283.20
1,299.40
450.30
1,317.50
2,738.10
Liabilities & Shareholders' Equity
1,883.50
1,989.40
1,173.10
2,131.20
3,397.10
About Kane Biotech
View Profile
